T
Power Law company profile
Tilray
Biotech & Life Sciences · Nanaimo, Canada · Founded 2013 · IPO 2018 Unicorn
Valuation
$832M
Market cap · Apr/2026
Revenue
$821M
Latest reported FY
Global footprint
Where Tilray has talent and traffic
AI talent share
0.3%
of workforce is AI talent
(3 of 984 staff)
(3 of 984 staff)
Core AI00%
Other AI30.3%
Non-AI workforce98199.7%
Web traffic by country
97K
monthly visits
across markets
across markets
🇨🇦 Canada44.5%
🇬🇧 United Kingdom29%
🇺🇸 United States14.8%
🇦🇺 Australia3%
🇩🇪 Germany1.9%
Patent intelligence
$450k patent portfolio · 5 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$450k
0.05% of market cap · 703.5× smaller than top peer BioMarin Pharmaceutical ($317M)
5 active patent families
Where Tilray innovates
Cannabis substanceCannabinoidPharmacologyMedicinal chemistryTetrahydrocannabinol
Below peer median on Legal, Strategic, Market, Economic, Technology
Quality vs same-sector peers
Tilray on the five Patsnap quality dimensions
Tilray in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Tilray concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Tilray and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Tilray on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.